Latest Insider Transactions at Atri Cure, Inc. (ATRC)
This section provides a real-time view of insider transactions for Atri Cure, Inc. (ATRC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AtriCure, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AtriCure, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
4,000
-0.56%
|
-
|
|
Mar 05
2025
|
Karen Prange Director |
SELL
Open market or private sale
|
Direct |
6,100
-25.49%
|
$231,800
$38.12 P/Share
|
|
Mar 01
2025
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,870
-12.72%
|
$375,060
$38.74 P/Share
|
|
Mar 01
2025
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,938
+14.62%
|
-
|
|
Mar 01
2025
|
Deborah Lee Yount Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,961
-20.79%
|
$454,518
$38.74 P/Share
|
|
Mar 01
2025
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,853
+20.52%
|
-
|
|
Mar 01
2025
|
Michael H Carrel President, CEO, & Director |
SELL
Payment of exercise price or tax liability
|
Direct |
43,926
-5.82%
|
$1,669,188
$38.74 P/Share
|
|
Mar 01
2025
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
101,242
+6.5%
|
-
|
|
Mar 01
2025
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,673
-10.01%
|
$367,574
$38.74 P/Share
|
|
Mar 01
2025
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,938
+12.03%
|
-
|
|
Mar 01
2025
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,672
-11.28%
|
$367,536
$38.74 P/Share
|
|
Mar 01
2025
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,938
+13.39%
|
-
|
|
Mar 01
2025
|
Salvatore Privitera Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,397
-6.31%
|
$319,086
$38.74 P/Share
|
|
Mar 01
2025
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,165
+9.92%
|
-
|
|
Mar 01
2025
|
Douglas J Seith Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,050
-7.58%
|
$571,900
$38.74 P/Share
|
|
Mar 01
2025
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,386
+10.25%
|
-
|
|
Mar 01
2025
|
Angela L Wirick Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,633
-7.64%
|
$518,054
$38.74 P/Share
|
|
Mar 01
2025
|
Angela L Wirick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,333
+9.99%
|
-
|
|
Dec 11
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Bona fide gift
|
Direct |
585
-0.82%
|
-
|
|
Aug 15
2024
|
Maggie Yuen Director |
SELL
Open market or private sale
|
Direct |
3,500
-28.07%
|
$84,000
$24.07 P/Share
|
|
Aug 14
2024
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
3,000
-0.46%
|
-
|
|
Jun 28
2024
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
707
+1.45%
|
$13,433
$19.35 P/Share
|
|
Jun 28
2024
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
707
+1.17%
|
$13,433
$19.35 P/Share
|
|
Jun 28
2024
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
707
+0.68%
|
$13,433
$19.35 P/Share
|
|
Jun 28
2024
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
707
+0.11%
|
$13,433
$19.35 P/Share
|
|
Jun 28
2024
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
707
+1.35%
|
$13,433
$19.35 P/Share
|
|
Jun 28
2024
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
707
+0.46%
|
$13,433
$19.35 P/Share
|
|
Jun 01
2024
|
Deborah Lee Yount Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,651
-5.85%
|
$58,322
$22.54 P/Share
|
|
May 30
2024
|
Salvatore Privitera Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+4.62%
|
$110,000
$22.25 P/Share
|
|
May 13
2024
|
Sven Wehrwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+21.19%
|
-
|
|
May 13
2024
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+31.7%
|
-
|
|
May 13
2024
|
Regina E Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+20.2%
|
-
|
|
May 13
2024
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+14.92%
|
-
|
|
May 13
2024
|
Maggie Yuen Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+38.44%
|
-
|
|
May 13
2024
|
Robert S. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+7.45%
|
-
|
|
May 13
2024
|
Shlomo Nachman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+37.27%
|
-
|
|
May 13
2024
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,788
+24.56%
|
-
|
|
May 01
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,500
-2.06%
|
$36,000
$24.09 P/Share
|
|
Apr 01
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,500
-2.02%
|
$45,000
$30.39 P/Share
|
|
Mar 18
2024
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,885
-3.57%
|
$60,320
$32.16 P/Share
|
|
Mar 14
2024
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
2,000
-0.3%
|
-
|
|
Mar 12
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.98%
|
$54,000
$36.72 P/Share
|
|
Mar 05
2024
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,231
-13.48%
|
$304,547
$37.36 P/Share
|
|
Mar 01
2024
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,855
-13.04%
|
$318,780
$36.28 P/Share
|
|
Mar 01
2024
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,622
+18.42%
|
-
|
|
Mar 01
2024
|
Douglas J Seith Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,596
-8.68%
|
$525,456
$36.28 P/Share
|
|
Mar 01
2024
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,104
+15.27%
|
-
|
|
Mar 01
2024
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,281
+20.66%
|
-
|
|
Mar 01
2024
|
Angela L Wirick Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.47%
|
$80,000
$16.95 P/Share
|
|
Mar 01
2024
|
Angela L Wirick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,469
+15.9%
|
-
|